We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Perhaps the most significant disconnect between the US government and the American people is the current federal marijuana laws. According to a recent Gallop survey, half of Americans indicate that they have tried marijuana, a new peak in the poll and a noticeable increase versus the 45% who said they had tried marijuana five years ago. Currently, the use and possession of cannabis is illegal under federal law due to the Controlled Substances Act (CSA) of 1970. However, in recent years, a noticeable grassroots uprising has occurred on a state level. Since Colorado and Washington became the first states to legalize the recreational use of cannabis in 2012, there has been a domino effect of states following through. Recreational marijuana is now legal in 23 states – and many other states like Florida have legalized marijuana for medical purposes, but not for recreational use.
Despite the growth in marijuana legalization statewide, public marijuana stocks have been decimated. Since its inception in the second quarter of 2022, the Roundhill Cannabis ETF ((WEED - Free Report) ) is down nearly 70%. The weakness in weed stocks is due to the failure to pass the SAFE Banking Act – a bill that would permit more banks to do business with legal marijuana companies.
Image Source: Zacks Investment Research
Marijuana Stocks: Don’t Lose Hope Yet
With the recovery in US equity markets and the underperformance in pot stocks, there has been little reason to enter them – that is, until now. Below are 3 reasons to buy marijuana stocks:
HHS Rescheduling Recommendation
Wednesday, game-changing industry news broke that the United States Department of Health and Human Services (HHS) is recommending that cannabis be changed from a Schedule 1 drug to a decidedly less prohibitive Schedule 3. Schedule 1 drugs include heroin, LSD, and ecstasy. In a statement, an HHS spokesperson said, “We believe that rescheduling to Schedule III will mark the most significant federal cannabis reform in modern history." While the Drug Enforcement Agency (DEA) will still need to review the request, the odds favor that marijuana will be moved to a Schedule 3 drug in the next few years – a major win for the industry. In the short-term to mid-term, HHS’s surprise change to its stance toward marijuana classification should act as a much-needed morale boost.
Outside Investment
Alcohol distribution giant Constellation Brands ((STZ - Free Report) ) invested over $4 billion in marijuana firm Canopy Growth ((CGC - Free Report) ). Despite the brutal bear market in shares of marijuana stocks, STZ remains committed to the business – showing firm conviction. As the laws in the United States become more favorable for pot companies, more companies like Constellation Brands may look to diversify their businesses and get a piece of marijuana stocks while they are on sale.
Reversion to the mean potential
When stocks are beaten down, and positive news emerges, the potential for a reversion to the mean trade comes to the forefront. The Weed ETF is showing clear signs of a change in character. Thursday, WEED crossed above its 200-day moving average for the first time in its history as volume spiked by more than 1,000% on the session.
GTBIF is one of the largest producers of marijuana in the United States. In an industry filled with unprofitable companies, GTBIF is one of the few that has achieved profitability in recent years.
TLRY offers investors a uniquely positioned, diverse company. After Anheuser-Busch ((BUD - Free Report) ) saw sales plunge after receiving backlash for featuring trans activist Dylan Mulvaney, TLRY bought eight beer brands from the beer giant. Tilray is not only one of the largest marijuana companies, it is also now the fifth-largest craft brewer in the United States. TLRY shares earn the best possible Zacks Growth Style Score of A.
IIPR is a REIT that deals in real estate assets used for growing medical marijuana. Though the stock is not a “pure play,” it will be a direct beneficiary if the industry is to turn around.
ETFs
Because the marijuana industry is highly speculative, news-driven, and volatile, risk-averse investors looking to enter the industry may want to consider the WEED or ALT Harvest ETF ((MJ - Free Report) ) as a diverse and less volatile means of playing the marijuana industry.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Time to Get High on Pot Stocks? (3 Catalysts)
Perhaps the most significant disconnect between the US government and the American people is the current federal marijuana laws. According to a recent Gallop survey, half of Americans indicate that they have tried marijuana, a new peak in the poll and a noticeable increase versus the 45% who said they had tried marijuana five years ago. Currently, the use and possession of cannabis is illegal under federal law due to the Controlled Substances Act (CSA) of 1970. However, in recent years, a noticeable grassroots uprising has occurred on a state level. Since Colorado and Washington became the first states to legalize the recreational use of cannabis in 2012, there has been a domino effect of states following through. Recreational marijuana is now legal in 23 states – and many other states like Florida have legalized marijuana for medical purposes, but not for recreational use.
Despite the growth in marijuana legalization statewide, public marijuana stocks have been decimated. Since its inception in the second quarter of 2022, the Roundhill Cannabis ETF ((WEED - Free Report) ) is down nearly 70%. The weakness in weed stocks is due to the failure to pass the SAFE Banking Act – a bill that would permit more banks to do business with legal marijuana companies.
Image Source: Zacks Investment Research
Marijuana Stocks: Don’t Lose Hope Yet
With the recovery in US equity markets and the underperformance in pot stocks, there has been little reason to enter them – that is, until now. Below are 3 reasons to buy marijuana stocks:
HHS Rescheduling Recommendation
Wednesday, game-changing industry news broke that the United States Department of Health and Human Services (HHS) is recommending that cannabis be changed from a Schedule 1 drug to a decidedly less prohibitive Schedule 3. Schedule 1 drugs include heroin, LSD, and ecstasy. In a statement, an HHS spokesperson said, “We believe that rescheduling to Schedule III will mark the most significant federal cannabis reform in modern history." While the Drug Enforcement Agency (DEA) will still need to review the request, the odds favor that marijuana will be moved to a Schedule 3 drug in the next few years – a major win for the industry. In the short-term to mid-term, HHS’s surprise change to its stance toward marijuana classification should act as a much-needed morale boost.
Outside Investment
Alcohol distribution giant Constellation Brands ((STZ - Free Report) ) invested over $4 billion in marijuana firm Canopy Growth ((CGC - Free Report) ). Despite the brutal bear market in shares of marijuana stocks, STZ remains committed to the business – showing firm conviction. As the laws in the United States become more favorable for pot companies, more companies like Constellation Brands may look to diversify their businesses and get a piece of marijuana stocks while they are on sale.
Reversion to the mean potential
When stocks are beaten down, and positive news emerges, the potential for a reversion to the mean trade comes to the forefront. The Weed ETF is showing clear signs of a change in character. Thursday, WEED crossed above its 200-day moving average for the first time in its history as volume spiked by more than 1,000% on the session.
Image Source: TradingView
Stocks to Watch
Green Thumb Industries ((GTBIF - Free Report) )
GTBIF is one of the largest producers of marijuana in the United States. In an industry filled with unprofitable companies, GTBIF is one of the few that has achieved profitability in recent years.
Image Source: Zacks Investment Research
Tilray Brands ((TLRY - Free Report) )
TLRY offers investors a uniquely positioned, diverse company. After Anheuser-Busch ((BUD - Free Report) ) saw sales plunge after receiving backlash for featuring trans activist Dylan Mulvaney, TLRY bought eight beer brands from the beer giant. Tilray is not only one of the largest marijuana companies, it is also now the fifth-largest craft brewer in the United States. TLRY shares earn the best possible Zacks Growth Style Score of A.
Image Source: Zacks Investment Research
Innovative Industrial Properties ((IIPR - Free Report) )
IIPR is a REIT that deals in real estate assets used for growing medical marijuana. Though the stock is not a “pure play,” it will be a direct beneficiary if the industry is to turn around.
ETFs
Because the marijuana industry is highly speculative, news-driven, and volatile, risk-averse investors looking to enter the industry may want to consider the WEED or ALT Harvest ETF ((MJ - Free Report) ) as a diverse and less volatile means of playing the marijuana industry.